Found 258 with Last Name = 'ebner' and Initial = 'dc' 
Affinity DataKi: 4nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
Affinity DataKi: 9nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
Affinity DataKi: 9nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
Affinity DataKi: 12nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
Affinity DataKi: 12nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
Affinity DataKi: 19nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
Affinity DataKi: 19nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
Affinity DataKi: 70nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
3D Structure (crystal)
Affinity DataKi: 85nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
Affinity DataKi: 214nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
Affinity DataKi: 300nMAssay Description:Displacement of [125I]GIP from human GIPRMore data for this Ligand-Target Pair
Affinity DataKi: 300nMAssay Description:Displacement of [125I]GIP from human GIPRMore data for this Ligand-Target Pair
Affinity DataKi: 356nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
Affinity DataKi: 430nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
Affinity DataKi: 430nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
Affinity DataKi: 556nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
Affinity DataKi: 600nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
Affinity DataKi: 816nMAssay Description:Displacement of [125I]GLP-1 from human GLP1RMore data for this Ligand-Target Pair
Affinity DataKi: 816nMAssay Description:Displacement of [125I]GLP-1 from human GLP1RMore data for this Ligand-Target Pair
Affinity DataKi: 927nMAssay Description:Displacement of [125I]GIP from human GIPRMore data for this Ligand-Target Pair
Affinity DataKi: 927nMAssay Description:Displacement of [125I]GIP from human GIPRMore data for this Ligand-Target Pair
Affinity DataKi: 968nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
Affinity DataKi: 1.09E+3nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
Affinity DataKi: 1.11E+3nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
Affinity DataKi: 1.19E+3nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
Affinity DataKi: 1.45E+3nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
Affinity DataKi: 1.95E+3nMAssay Description:Displacement of [125I]GIP from human GIPRMore data for this Ligand-Target Pair
Affinity DataKi: 1.98E+3nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
Affinity DataKi: 2.16E+3nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
Affinity DataKi: 3.34E+3nMAssay Description:Displacement of [125I]GLP-1 from human GLP1RMore data for this Ligand-Target Pair
Affinity DataKi: 3.34E+3nMAssay Description:Displacement of [125I]GLP-1 from human GLP1RMore data for this Ligand-Target Pair
Affinity DataKi: 4.08E+3nMAssay Description:Displacement of [125I]GIP from human GIPRMore data for this Ligand-Target Pair
Affinity DataKi: 4.08E+3nMAssay Description:Displacement of [125I]GIP from human GIPRMore data for this Ligand-Target Pair
Affinity DataKi: 1.04E+4nMAssay Description:Displacement of [125I]GLP-1 from human GLP1RMore data for this Ligand-Target Pair
Affinity DataKi: 1.04E+4nMAssay Description:Displacement of [125I]GLP-1 from human GLP1RMore data for this Ligand-Target Pair
Affinity DataKi: 1.47E+4nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
Affinity DataKi: 2.18E+4nMAssay Description:Displacement of [125I]GLP-1 from human GLP1RMore data for this Ligand-Target Pair
Affinity DataKi: 2.18E+4nMAssay Description:Displacement of [125I]GLP-1 from human GLP1RMore data for this Ligand-Target Pair
Target5'-AMP-activated protein kinase catalytic subunit alpha-1/subunit beta-1/subunit gamma-1(Homo sapiens (Human))
Pfizer
US Patent
Pfizer
US Patent
Affinity DataEC50: 53.6nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
Target5'-AMP-activated protein kinase catalytic subunit alpha-1/subunit beta-1/subunit gamma-1(Homo sapiens (Human))
Pfizer
US Patent
Pfizer
US Patent
Affinity DataEC50: 93.5nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
Target5'-AMP-activated protein kinase catalytic subunit alpha-1/subunit beta-1/subunit gamma-1(Homo sapiens (Human))
Pfizer
US Patent
Pfizer
US Patent
Affinity DataEC50: 13.7nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
Target5'-AMP-activated protein kinase catalytic subunit alpha-1/subunit beta-1/subunit gamma-1(Homo sapiens (Human))
Pfizer
US Patent
Pfizer
US Patent
Affinity DataEC50: 16nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
Target5'-AMP-activated protein kinase catalytic subunit alpha-1/subunit beta-1/subunit gamma-1(Homo sapiens (Human))
Pfizer
US Patent
Pfizer
US Patent
Affinity DataEC50: 252nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
Target5'-AMP-activated protein kinase catalytic subunit alpha-1/subunit beta-1/subunit gamma-1(Homo sapiens (Human))
Pfizer
US Patent
Pfizer
US Patent
Affinity DataEC50: 111nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
Target5'-AMP-activated protein kinase catalytic subunit alpha-1/subunit beta-1/subunit gamma-1(Homo sapiens (Human))
Pfizer
US Patent
Pfizer
US Patent
Affinity DataEC50: 125nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
Target5'-AMP-activated protein kinase catalytic subunit alpha-1/subunit beta-1/subunit gamma-1(Homo sapiens (Human))
Pfizer
US Patent
Pfizer
US Patent
Affinity DataEC50: 36.9nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
Target5'-AMP-activated protein kinase catalytic subunit alpha-1/subunit beta-1/subunit gamma-1(Homo sapiens (Human))
Pfizer
US Patent
Pfizer
US Patent
Affinity DataEC50: 1.08E+3nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
Target5'-AMP-activated protein kinase catalytic subunit alpha-1/subunit beta-1/subunit gamma-1(Homo sapiens (Human))
Pfizer
US Patent
Pfizer
US Patent
Affinity DataEC50: 383nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
Target5'-AMP-activated protein kinase catalytic subunit alpha-1/subunit beta-1/subunit gamma-1(Homo sapiens (Human))
Pfizer
US Patent
Pfizer
US Patent
Affinity DataEC50: 30nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
Target5'-AMP-activated protein kinase catalytic subunit alpha-1/subunit beta-1/subunit gamma-1(Homo sapiens (Human))
Pfizer
US Patent
Pfizer
US Patent
Affinity DataEC50: 130nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
